Monday, July 15, 2013

Partnerships Asia Session Spotlight: The Partnership Tool Belt: Selecting the Right Partnership Model within a Sponsor & CRO Relationship

In the age of utilizing and leveraging external clinical capabilities, new and progressive partnership models have evolved to best serve the needs of both sponsors and providers. At Partnerships in Clinical Trials Asia, we will not only explore those partnerships, but report on if these new models are working. Learn how to best navigate your clinical development strategy from the lessons learned our featured panel session The Partnership Tool Belt: Selecting the Right Partnership Model within a Sponsor & CRO Relationship.

Partnerships in Clinical Trials Asia will take place September 4-6, 2013.  For more information on this session and the rest of the program, download the agenda.  If you'd like to join us in Shanghai, as a reader of this blog when you register to join us and mention code XP1875BLOG, you'll save 15% off the standard rate.  Have any questions or want to get involved? Feel free to email me at jpereira@iirusa.com.

Featured Session: The Partnership Tool Belt: Selecting the Right Partnership Model within a Sponsor & CRO Relationship

Featured Participants: Kristian Hubbard, Outsourcing Manager, Clinical Science and Operations, BRISTOL-MYERS SQUIBB, USA
Sally Sha, Director, Business Development, TIGERMED, CHINA
Dr. Timothy Low, Vice President, Medical Affairs, Asia Pacific, COVIDIEN, SINGAPORE
Jens Opitz, Head of Clinical Operations, MERZ PHARMACEUTICALS, GERMANY

About the session:
  • • The evolution in partnership value from the traditional transactional competency to a fully-integrated alliance
  • • How has the environment of risk undertaking changed for all stake holders?
  • • What strategic due diligence including geographic and cultural capabilities has to be done pre-project to ensure success of partnership?
  • • Necessities in the alliance framework including management of resources, senior support, geographical alignment and more




No comments: